Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNF?ARE Mice.

Chakraborty R, Maltz MR, Del Castillo D, Tandel PN, Messih N, Anguiano M, Lo DD. Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNF?ARE Mice. J Crohns Colitis. 2022 Jul 14; 16(6):978-991.

View in: PubMed

subject areas

Animals
Crohn Disease
Disease Progression
Ileitis
Mammals
Mice
Receptors, Tumor Necrosis Factor, Type I
Tumor Necrosis Factor-alpha

authors with profiles

David Lo

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support